세계의 아르보바이러스 검사 시장 : 부문별 예측(2025-2030년)

The Arbovirus Testing Market was valued at USD 1.24 billion in 2023, expected to reach USD 1.31 billion in 2024, and is projected to grow at a CAGR of 5.81%, to USD 1.85 billion by 2030.

Arbovirus testing refers to the diagnostic procedures employed to detect the presence of arboviruses, which are viruses transmitted to humans and animals via arthropods like mosquitoes and ticks. Given the rising incidence of arboviral infections such as Zika, Dengue, and West Nile Virus, the necessity for arbovirus testing has intensified, primarily to safeguard public health. This testing is crucial in both clinical and vector surveillance contexts and has applications spanning hospitals, diagnostic labs, research institutes, and field surveillance units. Market growth is fueled by heightened awareness of vector-borne diseases, increased government initiatives for outbreak control, and advancements in diagnostic technologies, including PCR and serological methods. The burgeoning demand for rapid, accurate, and point-of-care testing solutions spotlights an emerging opportunity, especially in endemic regions. However, market expansion is hindered by several factors: the high cost of advanced testing devices, logistical challenges in rural or resource-poor settings, and a shortage of skilled personnel to operate sophisticated diagnostic tools. Key areas for innovation include the development of low-cost portable diagnostic kits, enhancing the specificity and sensitivity of testing methods, and integrating artificial intelligence to predict outbreaks. Furthermore, emphasis on research to understand arbovirus mutation patterns and cross-reactivity in serological tests can propel advancements. Firms should consider collaborations with governments and NGOs to facilitate widespread adoption and deploy educational campaigns to amplify the significance of early diagnosis. The arbovirus testing market, while growing, is inherently dynamic and influenced by seasonal trends, regional disease prevalence, and health policy changes. As such, businesses in this domain must maintain agility, prioritize R&D investment, and leverage data analytics to capture emerging trends and tailor products to meet diverse regional needs, thereby securing a robust market position amidst evolving public health landscapes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Arbovirus Testing Market

The Arbovirus Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising rate of prevalence of arboviruses among population
  • Growing healthcare awareness and spending across economies
• Market Restraints
  • Accuracy issues associated with arbovirus testing methods
• Market Opportunities
  • Evolution of new testing model to swat mosquito-borne dengue fever
  • Rapid investments in modernized healthcare infrastructures
• Market Challenges
  • Stringent approval processes for arbovirus testing

Porter's Five Forces: A Strategic Tool for Navigating the Arbovirus Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Arbovirus Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Arbovirus Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Arbovirus Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Arbovirus Testing Market

A detailed market share analysis in the Arbovirus Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Arbovirus Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Arbovirus Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Arbovirus Testing Market

A strategic analysis of the Arbovirus Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Arbovirus Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abnova Corporation, Bio-Rad Laboratories, Inc., Biogenix Inc. Pvt. Ltd., Biolab Diagnostics {I}Pvt. Ltd., bioMerieux SA, Certest Biotec, S.L., Creative Diagnostics, Diasorin S.p.A., EUROIMMUN Medizinische Labordiagnostika AG, F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., Hologic, Inc., InBios International, Inc., Intec Products, Inc., Lexicare Pharma Pvt. Ltd., NovaTec Immundiagnostica GmbH, OriGene Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics, Reckon Diagnostics Pvt. Ltd., Response Biomedical Corporation, SD Biosensor Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Arbovirus Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Enzyme-linked Immunosorbent Assays (ELISAs) and RT-PCR Assays.
• Based on Component, market is studied across Instruments & Equipments, Laboratory Consumables, and Software & Data Management Solutions.
• Based on Indication, market is studied across Chikungunya, Dengue, West Nile Fever, Yellow Fever Virus, and Zika.
• Based on End-User, market is studied across Diagnostic Centers, Hospitals, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising rate of prevalence of arboviruses among population
    • 5.1.1.2. Growing healthcare awareness and spending across economies
  • 5.1.2. Restraints
    • 5.1.2.1. Accuracy issues associated with arbovirus testing methods
  • 5.1.3. Opportunities
    • 5.1.3.1. Evolution of new testing model to swat mosquito-borne dengue fever
    • 5.1.3.2. Rapid investments in modernized healthcare infrastructures
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent approval processes for arbovirus testing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Arbovirus Testing Market, by Type

• 6.1. Introduction
• 6.2. Enzyme-linked Immunosorbent Assays (ELISAs)
• 6.3. RT-PCR Assays

7. Arbovirus Testing Market, by Component

• 7.1. Introduction
• 7.2. Instruments & Equipments
• 7.3. Laboratory Consumables
• 7.4. Software & Data Management Solutions

8. Arbovirus Testing Market, by Indication

• 8.1. Introduction
• 8.2. Chikungunya
• 8.3. Dengue
• 8.4. West Nile Fever
• 8.5. Yellow Fever Virus
• 8.6. Zika

9. Arbovirus Testing Market, by End-User

• 9.1. Introduction
• 9.2. Diagnostic Centers
• 9.3. Hospitals
• 9.4. Research Institutes

10. Americas Arbovirus Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Arbovirus Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Arbovirus Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Abnova Corporation
• 3. Bio-Rad Laboratories, Inc.
• 4. Biogenix Inc. Pvt. Ltd.
• 5. Biolab Diagnostics {I}Pvt. Ltd.
• 6. bioMerieux SA
• 7. Certest Biotec, S.L.
• 8. Creative Diagnostics
• 9. Diasorin S.p.A.
• 10. EUROIMMUN Medizinische Labordiagnostika AG
• 11. F. Hoffmann-La Roche Ltd.
• 12. Getein Biotech, Inc.
• 13. Hologic, Inc.
• 14. InBios International, Inc.
• 15. Intec Products, Inc.
• 16. Lexicare Pharma Pvt. Ltd.
• 17. NovaTec Immundiagnostica GmbH
• 18. OriGene Technologies, Inc.
• 19. PerkinElmer, Inc.
• 20. Quest Diagnostics
• 21. Reckon Diagnostics Pvt. Ltd.
• 22. Response Biomedical Corporation
• 23. SD Biosensor Inc.
• 24. Siemens Healthineers AG
• 25. Thermo Fisher Scientific Inc.